Although not yet recommended by the National Comprehensive Cancer Network (NCCN) guidelines, several clinical studies and case reports of a PD-1 inhibitor in combination with chemotherapy used for advanced biliary tract cancers have been reported (5–8). The gene discussed is PDCD1; the disease is biliary tract neoplasm.